SCHEMBL25704040

SCHEMBL25704040

Bc1c(B)c(B)c(-c2ccc3[nH]c4ccc5c6ccccc6oc5c4c3c2)c(B)c1B

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.41
▸ ZAP70 P43403 1/20 0.41
▸ SYK P43405 1/20 0.41
▸ ALOX5 P09917 2/20 0.36
▸ MAP3K11 Q16584 2/20 0.35
▸ MAP3K9 P80192 1/20 0.35
▸ CDK4 P11802 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ GABRB2 P47870 1/20 0.33
▸ GABRA4 P48169 1/20 0.33
▸ GABRE P78334 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25704074 0.85 CASP3 (0.39) MAP3K11MAP3K9CDK4CCND1GABRP
SCHEMBL31447816 0.84 CDK4 (0.49) JAK2ZAP70SYKALOX5CDK4
SCHEMBL24644406 0.84 CDK4 (0.49) JAK2ZAP70SYKALOX5CDK4
SCHEMBL26500140 0.84 HCRTR1 (0.46) JAK2ZAP70SYKALOX5MAP3K11
SCHEMBL14979113 0.82 JAK2 (0.45) JAK2ZAP70SYKALOX5MAP3K11
SCHEMBL31846 0.79 GABRA1 (0.51) JAK2ZAP70SYKMAP3K11MAP3K9
SCHEMBL29819648 0.79 GABRA1 (0.51) JAK2ZAP70SYKMAP3K11MAP3K9
SCHEMBL29655467 0.79 GABRA1 (0.51) JAK2ZAP70SYKMAP3K11MAP3K9
SCHEMBL30104216 0.79 JAK2 (0.40) JAK2ZAP70SYKALOX5MAP3K11
SCHEMBL18646560 0.79 JAK2 (0.45) JAK2ZAP70SYKALOX5MAP3K11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230210000-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE KYULUX, INC. (JP) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230210000-A1 COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE DRD1, DRD2, DRD3 JAK2 2622/4885ZAP70 4759/4885SYK 4729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback